Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
15 Novembre 2024 - 12:57AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Adverum Biotechnologies, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value
(Title of Class of Securities)
00773U207
(CUSIP Number)
September 30, 2024
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule
pursuant to which this Schedule is filed:
| * | The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
| 1. |
NAMES
OF REPORTING PERSONS
Vivo
Opportunity Fund Holdings, L.P. |
| 2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐
(b) þ |
| 3. |
SEC USE
ONLY
|
| 4. |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware |
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE VOTING POWER
218,895 (1) |
| 6. |
SHARED VOTING POWER
0 |
| 7. |
SOLE DISPOSITIVE POWER
218,895 (1) |
| 8. |
SHARED DISPOSITIVE POWER
0 |
| 9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
218,895 (1) |
| 10. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
| 11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.1% (2) |
| 12. |
TYPE OF REPORTING PERSON
PN |
| (1) | The number represents shares of common stock, $0.0001 par value (the
“Common Stock”) of Adverum Biotechnologies, Inc. (the “Issuer”) held of record by Vivo Opportunity Fund Holdings,
L.P. as of October 31, 2024. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. |
| (2) | Based on 20,802,463 shares of Common Stock outstanding as of October
31, 2024, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission (the “SEC”)
on November 4, 2024. |
| 1. |
NAMES OF REPORTING PERSONS
Vivo Opportunity, LLC |
| 2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐
(b) þ |
| 3. |
SEC USE ONLY
|
| 4. |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE VOTING POWER
218,895 (1) |
| 6. |
SHARED VOTING POWER
0 |
| 7. |
SOLE DISPOSITIVE POWER
218,895 (1) |
| 8. |
SHARED DISPOSITIVE POWER
0 |
| 9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
218,895 (1) |
| 10. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
|
| 11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.1% (2) |
| 12. |
TYPE OF REPORTING PERSON
OO |
| (1) | The number represents shares of Common Stock of the Issuer held of
record by Vivo Opportunity Fund Holdings, L.P. as of October 31, 2024. Vivo Opportunity, LLC is the general partner of Vivo Opportunity
Fund Holdings, L.P. |
| (2) | Based on 20,802,463 shares of Common Stock outstanding as of October
31, 2024, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the SEC on November 4, 2024. |
| Item 1. |
(a) |
Name of Issuer: |
Adverum Biotechnologies, Inc. (the “Issuer”)
| |
(b) |
Address of Issuer’s Principal Executive Offices: |
100 Cardinal Way, Redwood City, CA 94063
| Item 2.
|
(a) |
Name of Person Filing: |
| (i) | Vivo Opportunity Fund Holdings, L.P. |
| (ii) | Vivo Opportunity, LLC |
| |
(b) |
Address of Principal Business Office or, if None, Residence: |
192 Lytton Avenue, Palo Alto, CA 94301
| (i) | Vivo Opportunity Fund Holdings, L.P., a Delaware limited
partnership; and |
| (ii) | Vivo Opportunity, LLC, a Delaware limited liability company.
Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. |
| |
(d) |
Title of Class of Securities: |
Common Stock, $0.0001 par value
00773U207
| Item 3. |
If This Statement is Filed Pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a: |
| |
(a) |
☐ |
Broker or dealer registered under Section 15 of the Act. |
| |
|
|
|
| |
(b) |
☐ |
Bank as defined in Section 3(a)(6) of the Act. |
| |
|
|
|
| |
(c) |
☐ |
Insurance company as defined in Section 3(a)(19) of the Act. |
| |
|
|
|
| |
(d) |
☐ |
Investment company registered under Section 8 of the Investment Company Act of 1940. |
| |
|
|
|
| |
(e) |
☐ |
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); |
| |
|
|
|
| |
(f) |
☐ |
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); |
| |
|
|
|
| |
(g) |
☐ |
A parent holding company or control person in accordance with § 240.13d-1(b)(l)(ii)(G); |
| |
|
|
|
| |
(h) |
☐ |
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; |
| |
|
|
|
| |
(i) |
☐ |
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; |
| |
|
|
|
| |
(j) |
☐ |
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); |
| |
|
|
|
| |
(k) |
☐ |
Group, in accordance with § 240.13d-1(b)(l)(ii)(K). |
If filing as a non-U.S. institution in accordance with §
240.13d-1(b)(1(ii)(j), please specify the type of institution: ________________
Not Applicable.
| |
(a) |
Amount Beneficially Owned: |
All securities are held of record by Vivo Opportunity Fund
Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P.
1.1%
| |
(c) |
Number of shares as to which such person has: |
| |
(i) |
Sole power to vote or to direct the vote: 218,895
shares |
| |
(ii) |
Shared power to vote or to direct the vote: 0 |
| |
(iii) |
Sole power to dispose or
to direct the disposition of: 218,895 shares |
| |
(iv) |
Shared power to dispose of or to direct the disposition of: 0 |
| Item 5. |
Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following
☒.
| Item 6. |
Ownership of More than Five Percent on Behalf of Another Person. |
Not Applicable.
| Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not Applicable.
| Item 8. |
Identification and Classification of Members of the Group. |
Not applicable.
| Item 9. |
Notice of Dissolution of Group. |
Not applicable.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction
having that purpose or effect, other than activities solely in connection with a nomination under §240.14a11.
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: November 14, 2024
Vivo Opportunity Fund Holdings, L.P.
| By: Vivo Opportunity, LLC, its General Partner |
|
| |
|
|
| /s/ Kevin Dai |
|
| Name: |
Kevin Dai |
|
| Title: |
Managing Member |
|
Vivo Opportunity, LLC
| /s/ Kevin Dai |
|
| Name: |
Kevin Dai |
|
| Title: |
Managing Member |
|
6
Adverum Biotechnologies (NASDAQ:ADVM)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Adverum Biotechnologies (NASDAQ:ADVM)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
